Academic Article
RDF
pages:
-
2-keto-3-deoxy-6-phosphogluconate aldolases as catalysts for stereocontrolled carbon-carbon bond formation
-
2-Mercapto-Quinazolinones as Inhibitors of Type II NADH Dehydrogenase and Mycobacterium tuberculosis: Structure-Activity Relationships, Mechanism of Action and Absorption, Distribution, Metabolism, and Excretion Characterization
-
2-Tetradecylglycidic acid, an inhibitor of carnitine palmitoyltransferase-1, induces myocardial hypertrophy via the AT1 receptor
-
2-YEAR CLINICAL-EVALUATION OF CERAMIC INLAYS
-
2.4 Measuring Cytokine Responses by ELISA, ELISPOT and RT-PCR Methods
-
20 things you didnt know about blood transfusion
-
20 years of community nursing service: Memphis Sexual Assault Resource Center.
-
20,23-dihydroxyvitamin D3, novel P450scc product, stimulates differentiation and inhibits proliferation and NF-κB activity in human keratinocytes
-
20-hydroxycholecalciferol, product of vitamin D3 hydroxylation by P450scc, decreases NF-κB activity by increasing IκBα levels in human keratinocytes
-
20-Hydroxyvitamin D 3 inhibits proliferation of cancer cells with high efficacy while being non-toxic
-
20-Hydroxyvitamin D2 is a noncalcemic analog of vitamin D with potent antiproliferative and prodifferentiation activities in normal and malignant cells
-
20-Hydroxyvitamin D3, a product of vitamin D3 hydroxylation by cytochrome P450scc, stimulates keratinocyte differentiation
-
20-Year-Old Amish Woman With Abdominal Pain, Retroperitoneal Mass, and Hyperlipidemia
-
2003 Congress of Neurological Surgeons presidential address. The value of neurosurgery.
-
2004 AONE award winner profiles: Organizational innovation in nursing leadership
-
2005 AONE award winner profiles: Nurse executive scholarship
-
2007 Guideline for the Management of Ureteral Calculi
-
2007 Guideline for the Management of Ureteral Calculi
-
2008 ACLPS panel discussion on resident education in clinical pathology
-
2010 Accounting Program Annual Report
-
2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features.
-
2012 American college of rheumatology guidelines for management of gout. part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia
-
2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis.
-
2012 update of the 2008 American college of rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis
-
2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors
-
2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors
-
2013 Dahl Lecture American heart association council for high blood pressure research clarifying the physiology of endothelin
-
2013 European society of hypertension/European society of cardiology hypertension guidelines
-
2013 Update of the 2011 American College of Rheumatology Recommendations for the treatment of juvenile idiopathic arthritis: Recommendations for the medical therapy of children with systemic juvenile idiopathic arthritis and tuberculosis screening among children receiving biologic medications
-
2013 Update of the 2011 American college of rheumatology recommendations for the treatment of juvenile idiopathic arthritis: Recommendations for the medical therapy of children with systemic juvenile idiopathic arthritis and tuberculosis screening among children receiving biologic medications
pages:
